HOLD - Maintain neutral weight. Wait for breakout above $141.01 with volume or breakdown below $134.78. Do not add at unconfirmed levels.

• NII grew 12.9% year-over-year last quarter, but ROE of 8.53% sits below cost of equity—single quarter does not confirm an earnings inflection
• Net debt doubled from $18 billion to $36 billion in six months while equity base remained roughly flat, deteriorating leverage ratios
• EPS growth is buyback-engineered with 8.3% share count reduction over the past year, masking weak organic earnings power
• Technical setup shows no confirmation: 50 SMA flattening, RSI rejected at 60 twice in last month, volume 6.65 million shares below recent average
• Real downside risk is 6.5% to lower Bollinger band at $128.89, not 2.2% to 50 SMA stop—the aggressive analyst cherry-picks the first stop level
• Catalysts are fragile: China brokerage license not yet received (expected ≠ received), CPI print is two-sided risk, DBS tokenization is a single milestone not revenue-generating
• Macro picture relies on Polymarket signals (93% probability of no cuts) since FRED data was unavailable—prediction markets can be wrong on rate calls
• Traders plan already established entry at $141.01; aggressive analyst overriding the traders own risk framework for marginal entry improvement

→ vs aggressive: Extrapolating one quarter of NII growth into a permanent re-rating is narrative, not analysis. Until the next two quarters confirm, trailing data shows ROE below cost of equity and value destruction risk on capital deployed.

→ vs aggressive: Contradictory logic: acknowledging EPS is heavily buyback-engineered then dismissing that concern. Removing the 8.3% share count reduction reveals much weaker organic EPS growth. Bull case is built on the most fragile earnings component.

→ vs aggressive: Coiled spring setups resolve in both directions—pretending direction is predetermined is selection bias. The aggressive analyst asks to deploy capital into a setup that has not confirmed its direction based on hope.

→ vs aggressive: Cherry-picking the tight $3 stop to 50 SMA while ignoring the fat tail: lower Bollinger band at $128.89 is nearly $9 below current levels (6.5% downside), and 200 SMA at $122.59 is another $6 below that.

→ vs aggressive: The traders plan already established entry at $141.01 on confirmed breakout with volume. The aggressive analyst arguing for current entry is effectively overriding the traders own risk framework—this is contradictory and telling.

SCALE-IN-HOLD: Add 30-40% of intended full position at current levels (~137.80) with hard stop at $134.78; on confirmed breakout above $141.01 with volume, add remainder to full position. Exit anticipatory tranche on daily close below $134.78.

• Scaled entry: 30-40% now at ~$137.80, 60-70% on breakout confirmation above $141.01
• Breakout trigger: $141.01 with volume confirms bullish thesis
• Hard stop: $134.78 (invalidation of coiled-base thesis if 50 SMA fails)
• ATR: $3.04; risk per tranche ~1x ATR
• Total portfolio risk: 1-1.5% of capital
• Time horizon: 2-6 week catalyst window (CPI print this week, China catalyst imminent, Q3 earnings)
• Challenges aggressive: 50 SMA flattening, RSI rejected at 60 twice, no conviction break of $141 in 8 sessions, real risk-reward closer to 1.5-to-1 than 3-to-1 given 55-60% historical breakout success rate
• Challenges conservative: ROE 8.53% is lagging indicator; NII +12.9% YoY, pretax income +54%, EPS +60% show inflection; buybacks signal management believes stock undervalued
• Coiled spring prerequisites (volume expansion, breadth confirmation, breakout on heavy flows) not yet present

→ vs aggressive: Real downside risk is 2.2% to 6.5% not 2.2% (contingent on 50 SMA holding at $137.49; if it fails, next stop is $128.89 or $8.91 away, then $122.59); risk-reward collapses from 3-to-1 to ~1.5-to-1 when accounting for 55-60% historical breakout success rate in coiled bases

→ vs conservative: ROE 8.53% is a lagging indicator; NII +12.9% YoY, pretax income +54%, EPS +60% represent operational leverage from higher-for-longer rates; cannot simultaneously argue stock is fairly valued AND that management is making a capital allocation mistake buying it back